A Pilot Trial of RNS60 in Amyotrophic Lateral Sclerosis

INTRODUCTION: RNS60 is a novel immune-modulatory agent that has shown neuroprotective effects in ALS pre-clinical models. RNS60 is administered by weekly intravenous infusion and daily nebulization. The objective of this pilot open-label trial was to test the feasibility, safety, and tolerability of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Muscle Nerve
Main Authors: Paganoni, Sabrina, Alshikho, Mohamad J., Luppino, Sarah, Chan, James, Pothier, Lindsay, Schoenfeld, David, Andres, Patricia L., Babu, Suma, Zürcher, Nicole R., Loggia, Marco L., Barry, Robert L., Luotti, Silvia, Nardo, Giovanni, Trolese, Maria Chiara, Pantalone, Serena, Bendotti, Caterina, Bonetto, Valentina, De Marchi, Fabiola, Rosen, Bruce, Hooker, Jacob, Cudkowicz, Merit, Atassi, Nazem
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6379136/
https://ncbi.nlm.nih.gov/pubmed/30458059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.26385
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados